Press Releases

News Brief

Samsung Biologics to attend DCAT Week, expand U.S. presence with New Jersey site

Samsung Biologics to attend DCAT Week, expand U.S. presence with New Jersey site
 

Samsung Biologics is participating in DCAT Week 2023 from March 20 to 23. Kevin Sharp, VP and Head of Samsung Biologics America Sales, will talk about the company’s manufacturing capacity expansion plans in a speaking session during the Member Company Announcement Forum at the event. 

 

Already boasting 604,000 liters of biomanufacturing capacity upon the completion of its Plant 4 by midyear, Samsung Biologics is expected to maintain its capacity leadership with the addition of Plant 5 which is planned in its second Bio Campus.

 

The company is also expanding its U.S. presence through opening a new regional office in Ridgefield Park, New Jersey next week as part of the company’s efforts to enable streamlined communication and to work in closer proximity to its clients based in the U.S. and Europe.

Samsung Biologics to attend DCAT Week, expand U.S. presence with New Jersey site
 

Samsung Biologics is participating in DCAT Week 2023 from March 20 to 23. Kevin Sharp, VP and Head of Samsung Biologics America Sales, will talk about the company’s manufacturing capacity expansion plans in a speaking session during the Member Company Announcement Forum at the event. 

 

Already boasting 604,000 liters of biomanufacturing capacity upon the completion of its Plant 4 by midyear, Samsung Biologics is expected to maintain its capacity leadership with the addition of Plant 5 which is planned in its second Bio Campus.

 

The company is also expanding its U.S. presence through opening a new regional office in Ridgefield Park, New Jersey next week as part of the company’s efforts to enable streamlined communication and to work in closer proximity to its clients based in the U.S. and Europe.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION